Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM1WMOK)

Drug Name

Generx Drug Info

Synonyms

Alferminogene tadenovec

Indication

Disease Entry	ICD 11	Status	REF
Angina pectoris	BA40	Phase 3	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Fibroblast growth factor-4 (FGF4)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Pentosan Polysulfate	DM2HRKE	Interstitial cystitis	GC00.3	Approved	[3]
Ad5FGF-4	DMVLWG7	Angina pectoris	BA40	Phase 3	[4]
Alferminogene tadenovec	DMPH1RK	Angina pectoris	BA40	Phase 3	[5]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Fibroblast growth factor-4 (FGF4)	TTCEKVZ	FGF4_HUMAN	Replacement	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01550614) Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease (ASPIRE). U.S. National Institutes of Health.
2	Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials. J Am Coll Cardiol. 2007 Sep 11;50(11):1038-46.
3	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
4	Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease. Am J Cardiol. 2003 Nov 7;92(9B):24N-31N.
5	Alferminogene tadenovec, an angiogenic FGF4 gene therapy for coronary artery disease. IDrugs. 2008 Apr;11(4):283-93.